Skip to main content
Clinical Trials/EUCTR2009-013777-17-GB
EUCTR2009-013777-17-GBActive, not recruitingPhase 1

The effect of pamidronate treatment on bone health in patients with neuromuscular disease undergoing hip surgery. - Using pamidronate in patients with CP undergoing hip surgery.

Central Manchester and Manchester University Children's Hospital NHS Trust.0 sites12 target enrollmentStarted: March 17, 2010Last updated:
Conditions

Trial Snapshot

Phase
Phase 1
Status
Active, not recruiting
Sponsor
Enrollment
12

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Inclusion Criteria

  • All children with neuromuscular conditions between ages 6 and 16 undergoing hip surgery and post-op immobilisation in a hip spica at Royal Manchester Children's Hospital.
  • Exclusion criteria: Failure at screening. Not willing to participate in the study.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

Exclusion Criteria

  • Not provided

Investigators

Sponsor
Central Manchester and Manchester University Children's Hospital NHS Trust.

Similar Trials